Pharmafile Logo
Pharmafocus logo
Advanced Search

Forest’s COPD drug approved in US

March 3, 2011
Sales and Marketing COPD, Daliresp, Daxas, Forest, Forest Laboratories, chronic obstructive pulmonary disease, roflumilast

Daliresp (roflumilast) has been approved by the FDA to treat severe chronic obstructive pulmonary disease. Forest Laboratories’ once-daily pill is …

News
The RNA interference process

RNA interference – still the great white hope?

March 3, 2011
Manufacturing and Production, Research and Development RNA interference, rnai

The emerging field of RNA interference – also known as ‘gene silencing’ – is one of the most promising in …

Feature

NHS competition plans provide focus for dissent

March 3, 2011
Health and Social Care Bill, NHS, NHS reforms

Confusion and controversy surround the government plans to introduce greater levels of competition into the NHS, with many stakeholder groups …

Feature
EMD Serono headquarters

FDA knocks back Merck KGaA’s oral MS drug

March 2, 2011
Sales and Marketing Cladribine, EMD Serono, FDA, MS, Merck KGaA, Movectro, multiple sclerosis, oral MS drugs

US authorities have turned down Merck KGaA’s new drug application for its oral relapsing-remitting multiple sclerosis treatment Movectro. The FDA …

News

UCB teams up with Harvard for CNS research

March 2, 2011
Research and Development CNS, Harvard, UCB, academia, academic research, immunology

UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies. …

News
brecon_kay_ohagan

Boehringer’s Kay O’Hagan moves to Brecon

March 2, 2011
Manufacturing and Production, Research and Development Brecon, Kay O'Hagan, appointment, manufacturing and production, research and development

Kay O’Hagan has joined commercial packaging and clinical trials supply services company Brecon Pharmaceuticals as director of quality assurance and …

Appointment
Roche's Avastin (bevacizumab)

Avastin’s breast cancer use to continue in Europe

March 2, 2011
Sales and Marketing CHMP, Cancer, European Commission, Roche, avastin, bevacizumab, breast cancer, docetaxel, paclitaxel

Roche’s Avastin will remain on the market as a treatment for breast cancer, but only in combination with paclitaxel, the …

News

GlaxoSmithKline seeks alliances with ‘academic superstars’

March 2, 2011
Research and Development GSK, GlaxoSmithKline, Pentraxin Therapeutics, academia, al Free and University College Medical School, universities

GlaxoSmithKline has unveiled a partnership with a ‘superstar academic’, as part of a new strategy which it believes will help …

News

Daiichi Sankyo gains rights to potential blockbuster cancer drug

March 2, 2011
Research and Development BRAF protein, Daiichi Sankyo, PLX4032, Plexxikon, melanoma, personalised medicine

Daiichi Sankyo has purchased US-based discovery firm Plexxikon for $805 million, gaining access to its potential blockbuster melanoma drug PLX4032. …

News

Samsung forges biosimilar venture with Quintiles

March 2, 2011
Manufacturing and Production Quintiles, Samsung, biosimilar production, biosimilars, pharma production

South Korean electronics giant Samsung has formed a joint venture with Quintiles with the objective of breaking into the market …

News

Fujifilm buys into bio with Merck acquisitions

March 2, 2011
Manufacturing and Production Biomanufacturing, Fujifilm, Merck, Merck & Co, Merck/MSD Biomanufacturing Network, contract manufacturing

Japanese photography and imaging company Fujifilm continued its diversification into other sectors with the acquisition of the Merck/MSD Biomanufacturing Network, …

News
Bayer's Marijn Dekkers

Bayer goes for pharma growth

March 1, 2011
Research and Development, Sales and Marketing 2010 pharma results, Bayer, Dr Jörg Reinhardt, Marijn Dekkers, Nexavar, VEGF Trap-Eye, Xarelto

While many of its larger peers in the pharma sector are rushing to diversify into consumer health and generics, Bayer, …

Feature

Pfizer drops 15 pipeline projects

March 1, 2011
Research and Development Lyrica, Pfizer, Pfizer R&D, Pfizer product pipeline, Pfizer research, inotuzumab, pregabalin

Pfizer has again slimmed down its product pipeline as the US giant looks to cut R&D spending and sharpen its …

News

LEO Pharma Selects Veeva CRM for Pan-European Deployments

March 1, 2011
Sales and Marketing veeva

BARCELONA, SPAIN — 1 March, 2011 – LEO Pharma, a leading global pharmaceutical company specialising in dermatology and critical care, …

News
Press release

Dutch government sells off vaccine facility

March 1, 2011
Manufacturing and Production Bilthoven, Holland, NVI, Netherlands, Netherlands Vaccine Institute, vaccine manfacturing, vaccine production, vaccines

The Dutch government has put the manufacturing activities and capacity of the Netherlands Vaccine Institute in Bilthoven up for sale, …

News

Catalent sells off printed components business

March 1, 2011
Manufacturing and Production Catalent, Clondalkin, pharma packaging, pharmaceutical packaging

Catalent Pharma Solutions has agreed to sell its printed components business to Dutch packaging giant Clondalkin, which has been steadily …

News

Nampak to leave Portsmouth for new facility

March 1, 2011
Manufacturing and Production Nampak Healthcare, Portsmouth, Segensworth, pharma packaging, pharmaceutical carton facility

Nampak Healthcare plans to invest in a new manufacturing facility in Segensworth, UK, to overcome the limitations of its current …

News

Friedhelm Felten to head procurement at Merck

March 1, 2011
Manufacturing and Production, Research and Development Friedhelm Felten, Merck KGaA, appointment, manufacturing and production, research and development

Merck KGaA has appointed Friedhelm Felten as its new head of corporate procurement with responsibility for the group’s global purchasing …

Appointment

Forest depression candidate struggles against placebo

March 1, 2011
Research and Development Forest, Forest Laboratories, Gedeon Richter, cariprazine, depression, major depressive disorder

An investigational antipsychotic drug being developed by Forest Laboratories and Budapest-based Gedeon Richter has failed to prove itself in phase …

News

Pfizer in break up talks for Sandwich research site

March 1, 2011
Research and Development Kent, Pfizer, Sandwich, job cuts

Pfizer is in confidential talks over the future of its Sandwich, Kent research facility that could see the site broken …

News
The Gateway to Local Adoption Series

Latest content

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026